The bottom line is these medications should be $200-$300 a month, not $1300
PEP Talk Live Webinars Register For Upcoming Sessions Blood Thinners: The Dos, Donts & Research Thats Rewriting the Rules: August 11, 2026 Register Blood Clots & Compression One of our most popular topics compression & blood clots
The evidence base is preclinical for IGF-1 LR3 specifically, with adjacent human data from native rhIGF-1 (mecasermin/Increlex)
Supported by the substantial weight-loss efficacy of the GLP-1MK-801 conjugate and the potentiated hypothalamic changes in transcripts and proteins related to NMDA receptor-linked neuroplasticity, the alteration in MK-801 biodistribution governed by GLP-1-mediated targeting may effectively bypass the delivery of MK-801 to vagal afferent target neurons in the nucleus of the solitary tract
How Much Protein Do You Need on GLP-1 Medications
Its clinical development was halted, so there is no completed pivotal trial, no approved label, no reviewed dose, and no regulatory safety determination